E-Z-Em buys into ITI Technologies:
This article was originally published in Clinica
E-Z-Em has purchased 25% of Lawrence Livermore Laboratories' spin-off company, ITI Medical Technologies, in order to develop and commercialise interventional MRI devices. E-Z-Em already makes MR-compatible biopsy needles and breast lesion marking systems. E-Z-Em, which claims to be the world's largest maker of contrast agents for gastrointestinal radiology, has also signed an agreement with Eastman Kodak to become a preferred supplier in Kodak's Procedure Cost Management Alliance.